Portage Biotech Inc. | Income Statement
Fiscal year is April-March. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
180.60
40.50
-
-
-
-
Gross Income
180.60
40.50
-
-
-
-
SG&A Expense
1,537.80
2,752.30
4,317.10
9,188.00
35,491.20
2,858.30
EBIT
1,357.20
2,792.80
4,317.10
9,188.00
35,491.20
2,858.30
Unusual Expense
162.10
3,839.40
4.10
-
-
-
Non Operating Income/Expense
49.40
5.60
-
-
-
161,718.40
Interest Expense
-
-
20.00
7.40
552.40
41.10
Pretax Income
1,469.80
6,626.60
4,341.20
9,195.40
36,043.60
158,819
Equity in Affiliates
-
-
-
-
35,402.30
-
Consolidated Net Income
1,469.80
6,626.60
4,341.20
9,195.40
641.30
158,819
Net Income
1,469.80
6,304.90
3,118.40
5,706.20
16,298.70
158,819
Net Income After Extraordinaries
1,469.80
6,304.90
3,118.40
5,706.20
16,298.70
158,819
Net Income Available to Common
1,469.80
6,304.90
3,118.40
5,706.20
16,298.70
158,819
EPS (Basic)
0.02
0.04
0.02
0.02
0.06
0.59
Basic Shares Outstanding
80,403.20
161,977.20
193,442.50
239,745.00
254,043.10
267,796
EPS (Diluted)
0.02
0.04
0.02
0.02
0.06
0.59
Diluted Shares Outstanding
80,403.20
161,977.20
193,442.50
239,745.00
272,193.30
269,642
EBITDA
1,355.40
2,791.60
4,317.10
9,188.00
35,491.20
2,858.30
Other Operating Expense
-
0.00
-
-
-
-
Minority Interest Expense
-
321.70
1,222.80
3,489.20
16,939.90
-
About Portage Biotech
View Profile
